LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.60 | 27.76 | 3020 | 7045 | 0.4286 | 0.7987 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.60 | 27.76 | 445 | 7045 | 0.0632 | 0.4153 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.60 | 27.76 | 3372 | 7045 | 0.4786 | 0.8237 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.31 | 27.76 | 212 | 6976 | 0.0304 | 0.2904 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.31 | 27.76 | 3084 | 6976 | 0.4421 | 0.8054 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.31 | 27.76 | 479 | 6976 | 0.0687 | 0.4293 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.31 | 27.76 | 3475 | 6976 | 0.4981 | 0.8326 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.01 | 27.76 | 161 | 7000 | 0.0230 | 0.2465 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.01 | 27.76 | 3140 | 7000 | 0.4486 | 0.8088 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.01 | 27.76 | 461 | 7000 | 0.0659 | 0.4222 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.01 | 27.76 | 3542 | 7000 | 0.5060 | 0.8363 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 83.72 | 27.76 | 194 | 7055 | 0.0275 | 0.2755 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 83.72 | 27.76 | 3288 | 7055 | 0.4660 | 0.8177 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 83.72 | 27.76 | 511 | 7055 | 0.0724 | 0.4399 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 83.72 | 27.76 | 3691 | 7055 | 0.5231 | 0.8442 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 85.42 | 27.76 | 177 | 7025 | 0.0252 | 0.2612 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 85.42 | 27.76 | 3346 | 7025 | 0.4763 | 0.8225 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 85.42 | 27.76 | 505 | 7025 | 0.0719 | 0.4382 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 85.42 | 27.76 | 3805 | 7025 | 0.5416 | 0.8521 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.13 | 27.76 | 198 | 6987 | 0.0283 | 0.2793 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.13 | 27.76 | 3450 | 6987 | 0.4937 | 0.8306 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.13 | 27.76 | 525 | 6987 | 0.0751 | 0.4457 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.13 | 27.76 | 3886 | 6987 | 0.5561 | 0.8581 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 88.84 | 27.76 | 193 | 6965 | 0.0277 | 0.2754 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 88.84 | 27.76 | 3541 | 6965 | 0.5084 | 0.8373 | MN20160318_Q01 | H17 |